Proteasome inhibition therapies in childhood cancer.
Zaman
F
F
Fadeel
B
B
Sävendahl
L
L
D000818:Animals; D001846:Bone Development / Q000187:drug effects*; D001897:Boronic Acids / Q000009:adverse effects; D000069286:Bortezomib; D002648:Child; D019902:Chondrocytes / Q000187:drug effects; D006801:Humans; D051379:Mice; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011719:Pyrazines / Q000009:adverse effects
D001897:Boronic Acids; C423917:MG 262; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib